This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Fastly (FSLY) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
FSLYNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Spire (SPIR) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
Spire (SPIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SPIRPositive Net Change RDWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in ICF (ICFI): Can Its 3.6% Jump Turn into More Strength?
by Zacks Equity Research
ICF (ICFI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ICFINo Net Change MMSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Climb Global (CLMB) Moves 8.5% Higher: Will This Strength Last?
by Zacks Equity Research
Climb Global (CLMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CLMBNegative Net Change NOVNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arvinas (ARVN) Surges 9.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Arvinas (ARVN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ARVNNegative Net Change TECHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Profound Medical (PROF) Surges 6.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PROFPositive Net Change OPTNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
WSFS (WSFS) Moves 7.1% Higher: Will This Strength Last?
by Zacks Equity Research
WSFS (WSFS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
WSFSNegative Net Change FFICPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Essa Bancorp (ESSA) Moves 5.4% Higher: Will This Strength Last?
by Zacks Equity Research
Essa Bancorp (ESSA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ESSAPositive Net Change RVSBNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SiTime (SITM) Moves 5.1% Higher: Will This Strength Last?
by Zacks Equity Research
SiTime (SITM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SITMNegative Net Change TRMBNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
MoneyLion (ML) Moves 10.3% Higher: Will This Strength Last?
by Zacks Equity Research
MoneyLion (ML) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MLPositive Net Change VNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
by Zacks Equity Research
Evolent Health (EVH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EVHNegative Net Change THRYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in TechTarget (TTGT): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
TechTarget (TTGT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TTGTNegative Net Change ABNBPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AFC Gamma (AFCG) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
AFC Gamma (AFCG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AFCGPositive Net Change AGNCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
C4 Therapeutics (CCCC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CCCCNegative Net Change PRAXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Viridian Therapeutics (VRDN): Can Its 8.7% Jump Turn into More Strength?
by Zacks Equity Research
Viridian Therapeutics (VRDN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VRDNNo Net Change CLGNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Mativ Holdings (MATV): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
Mativ Holdings (MATV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MATVNegative Net Change VVVNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SoundThinking (SSTI) Soars 14.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
SoundThinking (SSTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SSTINegative Net Change JCINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?
by Zacks Equity Research
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRSPNegative Net Change AXSMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Innospec (IOSP) Stock Jumps 3.8%: Will It Continue to Soar?
by Zacks Equity Research
Innospec (IOSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IOSPNegative Net Change CMPNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Terex (TEX): Can Its 8.5% Jump Turn into More Strength?
by Zacks Equity Research
Terex (TEX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TEXNegative Net Change HYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in H&E Equipment (HEES): Can Its 7.5% Jump Turn into More Strength?
by Zacks Equity Research
H&E Equipment (HEES) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
HEESNegative Net Change CATNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nabors (NBR) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
Nabors (NBR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NBRNegative Net Change VALNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in USCB Financial (USCB): Can Its 7.3% Jump Turn into More Strength?
by Zacks Equity Research
USCB Financial (USCB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
USCBNegative Net Change CUBIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
First Financial Corp. (THFF) Soars 6.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
First Financial Corp. (THFF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
THFFNegative Net Change FIBKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Northrim (NRIM) Surges 7.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Northrim (NRIM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NRIMNegative Net Change ZIONNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today